WuXi PharmaTech has purchased a multiyear license to Simulations Plus’ ADMET Predictor, the company’s flagship structure-to-property prediction software for pharmaceutical discovery and development.   John DiBella, vice president of marketing and sales for Simulations Plus, said, “We’re very pleased that WuXi has elected to license the ADMET Predictor Toxicity Module, which provides more than 30 different kinds of toxicity predictions, requiring only molecular structures as input. These in silic...